Home » Topics » Regulatory

Regulatory
RSS

Lilly reports compounds for postmenopausal syndrome

April 15, 1997

Pharmacia & Upjohn introduces new GH delivery device

April 14, 1997

First CFC-free inhaler launched in U.S.

April 14, 1997

Tentative approval for Faulding's generic aciclovir for injection

April 14, 1997

Wyeth-Ayerst and Elan develop new formulation of Lodine

April 11, 1997

Aldara approved in U.S.

April 11, 1997

First launch for new indication of cabergoline

April 11, 1997

Selfadministration device for Imitrex available in the U.S.

April 9, 1997

Pharmacia & Upjohn's Rescriptor cleared by FDA

April 8, 1997

RPR's Tilade approved for pediatric use

April 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...